Home/Filings/4/0001415889-24-021189
4//SEC Filing

Forman Mark S 4

Accession 0001415889-24-021189

CIK 0001851194other

Filed

Aug 12, 8:00 PM ET

Accepted

Aug 13, 4:48 PM ET

Size

5.8 KB

Accession

0001415889-24-021189

Insider Transaction Report

Form 4
Period: 2024-08-12
Forman Mark S
Chief Medical Officer
Transactions
  • Award

    Stock Option (Right to Buy)

    2024-08-12+350,000350,000 total
    Exercise: $1.95Exp: 2034-08-12Common Stock (350,000 underlying)
Footnotes (1)
  • [F1]25% of the shares subject to the Option shall vest on the one year anniversary of the date of grant (the "Vesting Commencement Date"), and 1/48th of the shares subject to the Option shall vest each month thereafter on the same day of the month as the Vesting Commencement Date (and if there is no corresponding day, on the last day of the month), subject to the reporting person continuing to be a Service Provider (as defined in the Issuer's 2021 Equity Incentive Plan) through each such date.

Issuer

Ventyx Biosciences, Inc.

CIK 0001851194

Entity typeother

Related Parties

1
  • filerCIK 0001922353

Filing Metadata

Form type
4
Filed
Aug 12, 8:00 PM ET
Accepted
Aug 13, 4:48 PM ET
Size
5.8 KB